BALAXI.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana...

Stats
Šios dienos apimtis	3 584.00
Vidutinė apimtis	21 135.00
Rinkos kapitalizacija	6.38B
EPS	INR14.06 ( 2023-09-30 )
Last Dividend	INR0.500 ( 2022-07-01 )
Next Dividend	INR0 ( N/A )
P/E	-112.93
ATR14	INR1.779 (0.30%)

Tūris Koreliacija

Ilgas: -0.07 (neutral)

Trumpas: 0.59 (weak)

Signal:(55.51) Neutral

Balaxi Pharmaceuticals Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
LAKSHVILAS.NS	0.837
ASIANPAINT.NS	0.829
KIRIINDUS.NS	0.822
BGLOBAL.NS	0.819
DIXON.NS	0.802
DMART.NS	0.801

10 Labiausiai neigiamai susiję koreliacijos
DFMFOODS.NS	-0.833
TOUCHWOOD.NS	-0.827

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Balaxi Pharmaceuticals Koreliacija - Valiuta/Žaliavos

-0.35
( neutral )

-0.47
( neutral )

0.27
( neutral )

-0.46
( neutral )

-0.29
( neutral )

0.55
( weak )

Balaxi Pharmaceuticals Finansinės ataskaitos

Annual	2022
Pajamos:	INR3.36B
Bruto pelnas:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
Pajamos:	INR3.36B
Bruto pelnas:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
Pajamos:	INR2.79B
Bruto pelnas:	INR837.92M (29.99 %)
EPS:	INR47.66

FY	2021
Pajamos:	INR2.31B
Bruto pelnas:	INR591.85M (25.58 %)
EPS:	INR38.14

Financial Reports:

No articles found.

Balaxi Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Balaxi Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.50 - low (50.00%) | Divividend Growth Potential Score: 0.0536 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2022-07-01
Last Dividend	INR0.500	2022-07-01
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.500	--
Avg. Dividend % Per Year	0.02%	--
Score	0.4	--
Div. Sustainability Score	2.50
Div.Growth Potential Score	0.0536
Div. Directional Score	1.279	--

Next Divdend (Est)
(2024-04-28)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.40

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2022	INR0.500	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TOUCHWOOD.NS	Dividend Junior	2023-09-22	Annually	6	0.15%
PGIL.NS	Dividend Junior	2023-09-01	Annually	17	1.08%
JINDALSAW.NS	Dividend Junior	2023-06-13	Annually	22	1.62%
DEEPAKNTR.NS	Dividend Junior	2023-07-27	Annually	14	0.25%
SKMEGGPROD.NS	Dividend Junior	2023-08-30	Sporadic	21	0.95%
MGEL.NS	Dividend Junior	2023-08-08	Annually	5	0.59%
HARSHA.NS	Dividend Junior	2023-09-20	Insufficient data to determine frequency	2	0.09%
BDL.NS	Dividend Junior	2023-09-20	Semi-Annually	7	1.17%
PTC.NS	Dividend Knight	2023-09-20	Annually	21	6.06%
KDDL.NS	Dividend Junior	2023-09-22	Annually	8	0.29%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0199	1.500	-0.398	-0.597	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.0309	1.500	-1.454	-2.18	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	31.60	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.82	2.00	8.09	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.424	1.000	6.26	6.26	[0.2 - 0.8]
operatingProfitMarginTTM	0.161	1.000	8.77	8.77	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.50

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-114.64	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0309	2.50	-0.935	-2.18	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0149	1.000	-2.13	0	[0.1 - 0.5]
Total Score				0.0536

Balaxi Pharmaceuticals

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.